title: Are nomograms better than currently available stage groupings for bladder cancer?
authors.forename: Cora N
authors.initials: CN
authors.lastname: Sternberg
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000556:secondary; D002295:Carcinoma, Transitional Cell / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D015653:Cystectomy / Q000379:methods; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D020360:Neoadjuvant Therapy; D049451:Nomograms; D011237:Predictive Value of Tests; D011379:Prognosis; D012107:Research Design; D018570:Risk Assessment; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery